6 research outputs found
Upala pluÄa uzrokovana ventilatorom: usporedba bolesnika s kadaveriÄnim presatkom jetre i kirurÅ”kih bolesnika bez presatka
Ventilator-associated pneumonia is a frequent complication in intensive care surgical patients, particularly those with high severity scores on admission. We studied the incidence and clinical outcome of ventilator-associated pneumonia among patients undergoing major general surgery procedures and those undergoing cadaveric liver transplantation in our hospital. Patients with the intensive care unit stay longer than four days having undergone surgery or transplantation and mechanically ventilated for more than 48 hours were included in the study. Ventilator-associated pneumonia diagnosis was based on a combination of radiological signs (progressive infiltrate on chest radiograph), clinical signs (fever >38.3 Ā°C, leukocytes >12Ć109/mL) and microbiological data (positive culture from tracheal aspiration >105 or bronchoalveolar lavage >104 colonies/mL). Medical records of 1037 patients were reviewed and 157 patients were found to have been mechanically ventilated for
more than 48 hours: 62 transplanted and 95 non-transplanted. Only 39 (24.84%) patients matched the criteria for ventilator-associated pneumonia. There were no differences in sex, age, duration of mechanical ventilation, length of stay or outcome between the two groups. However, the main difference was the mean severity score on admission (Simplified Acute Physiology Score II) which was higher among non-transplant patients (42Ā±16 vs. 31Ā±9; p=0.03). Gram-negative bacteria were the leading causative agents (82.03%) and were multidrug-resistant. In the intensive care surgical population, transplantation per se does not seem to increase patient risk for either ventilator-associated pneumonia acquisition or worse outcomes.Upala pluÄa uzrokovana ventilatorom Äesta je komplikacija u jedinicama intenzivnog lijeÄenja kirurÅ”kih bolesnika, naroÄito onih s visokim stupnjem disfunkcije organa kod prijma. Ispitivala se uÄestalost i kliniÄki ishod upale pluÄa uzrokovane ventilatorom kod bolesnika podvrgnutih velikim abdominalnim operativnim zahvatima te kod bolesnika nakon kadaveriÄne transplantacije jetre. U studiju su bili ukljuÄeni bolesnici koji su u Jedinici intenzivnog lijeÄenja boravili duže od Äetiri dana, koji su proÅ”li operaciju ili transplantaciju te koji su bili mehaniÄki ventilirani duže od 48 sati. Dijagnoza se temeljila na kombinaciji radioloÅ”kih znakova (progresija infiltrata na snimkama prsiÅ”ta), kliniÄkih znakova (vruÄica >38,3 Ā°C, leukociti >12Ć109/mL) te mikrobioloÅ”kih podataka (pozitivna kultura aspirata traheje >105 i/ili bronhoalveolarnog lavata >104 kolonije/mL). Pregledani su medicinski zapisi 1037 bolesnika od kojih je njih 157 bilo mehaniÄki ventilirano duže od 48 sati: 62 transplantiranih i 95 netransplantiranih. Samo 39 (24,84%) bolesnika zadovoljilo je kriterije. Nije naÄena razlika u spolu, dobi, trajanju mehaniÄke ventilacije, duljini boravka ili ishodu izmeÄu ispitivanih skupina. MeÄutim, glavnu razliku Äinio je bodovni sustav disfunkcije organa kod prijma (Simplifi ed Acute Physiology Score II), koji je bio veÄi kod netransplantiranih bolesnika (42Ā±16 prema 31Ā±9; p=0,03). Multirezistentne gram-negativne bakterije bile su vodeÄi uzroÄnik (82,03%). U jedinicama intenzivnog lijeÄenja kirurÅ”kih bolesnika transplantacija jetre sama po sebi ne poveÄava rizik za nastanak upale pluÄa uzrokovane ventilatorom kao ni loÅ”iji ishod tih bolesnika
Treatment of haemorrhagic shock: a case report
Te aim of this case report is to demonstrate
that during extensive and long-lasting
mutilating operations it is necessary
to use an aggressive volume replacing approach
to maintain adequate tissue oxygenation.
A satisfactory level of tissue oxygenation
is necessary to uphold the function and
structure of cells, tissue and organs. Monitoring
the haemodynamic function during
the operation is an important task for the
anaesthesiologist.
We present a case of a 58-year-old woman
with widespread malignant disease, who
underwent surgical treatment in our hospital.
Te operation was mutilating and longlasting.
During the perioperative period
the patient received a large volume of fuids
and blood products due to extensive
intraoperative blood loss. High doses of
vasoactive drugs were also introduced to
achieve haemodynamic stability.
Due to adequate and aggressive volume
replacement, haemodynamic stability was
eventually achieved and the outcome was
benefcial for our patient
Viscoelastic hemostatic tests during liver transplantation ā have we changed blood transfusion therapy?
Uvod: Transplantacija ili presaÄivanje jetre jest priznata metoda lijeÄenja kojom se terminalno bolesna jetra zamjenjuje sa zdravom jetrom darivatelja. Standardni laboratorijski testovi (protrombinsko vrijeme, aktivirano parcijalno tromboplastinsko vrijeme, fibrinogen, antitrombin), premda koreliraju s težinom jetrene bolesti, pokazali su inferiornost u odnosu na viskolelastiÄne testove (trombelastogram ā TEG i rotacijska trombelastometrija ā ROTEM) u procjeni funkcije koagulacijskog sustava u terminalnoj fazi jetrene bolesti. Cilj ovog istraživanja bio je utvrditi na koji je naÄin intraoperacijska upotreba viskolestiÄnih testova u procjeni hemostaze tijekom transplantacije jetre utjecala na transfuzijsko lijeÄenje u KliniÄkoj bolnici Merkur. Metode: Ovom retrospektivnom, opservacijskom studijom analizirane su slijedeÄe varijable za 76 pacijenta iz 2010. (bez ROTEM-a) te 82 pacijenta iz 2021. (s ROTEM-om) kojima je u KB Merkuru transplantirana jetra : intraoperacijska nadoknada tekuÄinama (kristaloidne, koloidne otopine); transfuzijsko lijeÄenje krvnim derivatima (deplazmatizirani koncentrati eritrocita, svježe smrznuta plazma, trombociti, krioprecipitat); ukupni intraoperacijski gubitci (krv, diureza, meÄustaniÄni prostor); ukupna nadoknada tekuÄinama i krvnim derivatima. Rezultati: Tijekom 2010. prosjeÄna ukupna nadoknada tekuÄinama i krvnim derivatima bila je 18 433 ml dok je za 2021. bila 9838 ml (p<0,0001). ProsjeÄni volumen kristaloidnih otopina ordiniranih 2010. tijekom transplantacije jetre bio je 5674 ml dok je 2021. bio 4734 ml (p=0,0015); koloidnih 2010. godine 2244 ml, a koloidnih 2021. godine 1949 ml (p=0,07). ProsjeÄna koliÄina deplazmatiziranih eritrocita ordinirana 2010. bila je 2927 ml dok je 2021. bila 1266 ml (p<0,0001). ProsjeÄna koliÄina svježe smrznute plazme, trombocita i krioprecipitata ordiniranih 2010. bila je 5428, 426, 266 ml dok je 2021. bila 823 (p<0,0001), 137 (p<0,0001), 366 ml (p<0,03). ZakljuÄak: Uporabom viskoelastiÄnih testova za praÄenje hemostaze tijekom transplantacije jetre znaÄajno je smanjeno davanje svih krvnih derivata, osim krioprecipitata Äija potroÅ”nja je poveÄana, a nije utjecala na koliÄinu ordiniranih koloidnih otopina. Smanjenje koliÄine krvnih derivata je od iznimnog znaÄaja s obzirom na rizike koje nosi transfuzijsko lijeÄenje.Introduction: Liver transplantation is a viable treatment for end stage liver desease in which a terminally ill liver is replaced with a healthy donor liver. Standard laboratory tests (prothrombin time, activated partial thromboplastin time, fibrinogen, antithrombin), although correlates with the severity of liver disease, showed inferiority to viscolelastic tests (thrombelastogram ā TEG, rotational thrombelastometry ā ROTEM) in the assessment of coagulation in the end stage liver desease. The aim of this study was to determine if the intraoperative use of viscolastical tests during liver transplantation have influenced amount of administered blood products. Methods: This retrospective, observational study analyzed the following variables for 76 patients in 2010. (without ROTEM) and 82 patients in 2021. (with ROTEM) who underwent liver transplantation at University Hospital
Merkur: intraoperative fluid replacement (crystalloid, colloid); blood products (deplasmatized erythrocytes, fresh frozen plasma, platelets, cryoprecipitate); total intraoperative fluide losses (blood, diuresis, intercellular space); total compensation of fluids and blood products. Results: In 2010. the average total compensation of fluids and blood products was 18,433 ml, while in 2021. it was 9,838 ml (p <0.0001). Volume of crystalloids administered in 2010. was 5674 ml, in 2021. 4734 ml (p = 0.0015); colloids in 2010. 2244 ml, in 2021. 1949 ml (p = 0.07). Deplasmated erythrocytes administered in 2010. were 2927 ml while in 2021. 1266 ml (p <0.0001). Fresh frozen plasma, platelets and cryoprecipitates administered in 2010. were 5428, 426, 266 ml, in 2021. it was 823 (p <0.0001), 137 (p <0.0001), 366 ml (p <0, 03). Conclusion: The use of viscoelastic tests to monitor hemostasis during liver transplantation significantly reduced the administration of all blood products, except cryoprecipitates whose consumption was increased and did not affect the amount of administered colloids. Reducing the amount of blood products is important given the risks related to transfusion of blood products
Ventilator-associated pneumonia: comparing cadaveric liver transplant and non-transplant surgical patients
Ventilator-associated pneumonia is a frequent complication in intensive care surgical patients, particularly those with high severity scores on admission. We studied the incidence and clinical outcome of ventilator-associated pneumonia among patients undergoing major general surgery procedures and those undergoing cadaveric liver transplantation in our hospital. Patients with the intensive care unit stay longer than four days having undergone surgery or transplantation and mechanically ventilated for more than 48 hours were included in the study. Ventilator-associated pneumonia diagnosis was based on a combination of radiological signs (progressive infiltrate on chest radiograph), clinical signs (fever >38.3 Ā°C, leukocytes >12Ć109/mL) and microbiological data (positive culture from tracheal aspiration >105 or bronchoalveolar lavage >104 colonies/mL). Medical records of 1037 patients were reviewed and 157 patients were found to have been mechanically ventilated for
more than 48 hours: 62 transplanted and 95 non-transplanted. Only 39 (24.84%) patients matched the criteria for ventilator-associated pneumonia. There were no differences in sex, age, duration of mechanical ventilation, length of stay or outcome between the two groups. However, the main difference was the mean severity score on admission (Simplified Acute Physiology Score II) which was higher among non-transplant patients (42Ā±16 vs. 31Ā±9; p=0.03). Gram-negative bacteria were the leading causative agents (82.03%) and were multidrug-resistant. In the intensive care surgical population, transplantation per se does not seem to increase patient risk for either ventilator-associated pneumonia acquisition or worse outcomes